8. Мухин Н.А., Моисеев В.С., Кобалава Ж.Д. Поражение сердечно-сосудистой системы при заболеваниях почек. Национальное руководство / Под ред. Е. В. Шляхто. - 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2015. - C. 691 -694.
9. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная терапия и профилактика, 2011; 10 (6).
10. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Смирнов А.В., Шилов Е.М., Добронравов В.А., Каюков И.Г., Бобкова И.Н., Швецов М.Ю., Цыгин А.Н., Шутов А.М. Нефрология. 2012. Т. 16. №1. С.89-115.
11. Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302-308.
12. Bello AK, Ronksley PE, Tangri N, et al. Quality of chronic kidney disease management in Canadian primary care. JAMA Netw Open. 2019;2(9):e1910704.
13. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-130.
15. Kristensen C, Wish J. The 2009 proposed rule for prospective ESRD payment: perspectives from the forum of ESRD Networks. Am J Kidney Dis. 2010;55(2):234-236.
16. McCullough PA, Li S, Jurkovitz CT, et al; KEEP Investigators. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008;156(2):277-283.
17. Murphy DP, Drawz PE, Foley RN. Trends in angiotensin converting enzyme inhibitor and angiotensin II receptor blocker use among those with impaired kidney function in the United States. J Am Soc Nephrol. 2019;30(7):1314-1321.
18. Myers OB, Pankratz VS, Norris KC, Vassalotti JA, Unruh ML, Argyropoulos C. Surveillance of CKD epidemiology in the US: a joint analysis of NHANES and KEEP. Sci Rep. 2018;8(1):15900.
19. Nash DM, Brimble S, Markle-Reid M, et al. Quality of care for patients with chronic kidney disease in the primary care setting: a retrospective cohort study from Ontario, Canada. Can J Kidney Health Dis. 2017;4:2054358117703059.
20. Tangri N, Kitsios GD, Inker LA, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013;158(8):596-603.
21. Uhlig K, MacLeod A, Craig J, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 70(12):2058-2065.